PDF(Pubmed)
Abstract：
UNASSIGNED: Fractures of the clavicle are usually operated under general anesthesia (GA) as they need dense anesthesia, and the airway is difficult to access intraoperatively. There is no established regional anesthesia (RA) technique for clavicular fractures, also as the innervation is contentious. Some studies have been done using RA techniques, but they are all small case numbers. RA is superior to GA in many ways, and we wished to avoid GA specifically during the COVID-19 pandemic.
UNASSIGNED: This study aimed to use a peripheral nerve stimulator and a landmark-based technique to give interscalene block (ISB) and superficial cervical plexus block (SCPB) as a sole anesthetic for clavicular fracture surgeries during the COVID-19 pandemic.
UNASSIGNED: This was a prospective observational study in a tertiary care teaching hospital in eastern India.
UNASSIGNED: After approval from our ethics committee and informed consent, thirty patients of American Society of Anesthesiologists Class I or II, aged 18-65 years, after exclusion criteria were selected who had to undergo clavicular surgery. Three 10-mL syringes were made, each with 5 mL of 0.75% ropivacaine, 2 mL of 2% lignocaine with 1:200,000 adrenaline, and 3 mL of saline. Using the HNS Stimuplex (B. Braun Melsungen AG, Melsungen, Germany) nerve stimulator, 20 mL was given for an ISB and 5 mL for the SCPB. RA was considered successful if there was no conversion to GA and surgery could be performed.
UNASSIGNED: With an onset time of 6.53 ± 2.17 min, good operating conditions were obtained in all our patients. Horner\'s syndrome was noted in two patients. Surgery was successfully carried out in all thirty patients under RA. Pain relief lasted postoperatively for 5 ± 0.92 h.
UNASSIGNED: ISB combined with SCPB is safe and effective as a sole anesthetic for clavicular surgery. We successfully avoided the use of a general anesthetic in these patients during the COVID-19 pandemic and gave them a safe and effective alternative.
UNASSIGNED: This study aimed to use a peripheral nerve stimulator and a landmark-based technique to give interscalene block (ISB) and superficial cervical plexus block (SCPB) as a sole anesthetic for clavicular fracture surgeries during the COVID-19 pandemic.
UNASSIGNED: This was a prospective observational study in a tertiary care teaching hospital in eastern India.
UNASSIGNED: After approval from our ethics committee and informed consent, thirty patients of American Society of Anesthesiologists Class I or II, aged 18-65 years, after exclusion criteria were selected who had to undergo clavicular surgery. Three 10-mL syringes were made, each with 5 mL of 0.75% ropivacaine, 2 mL of 2% lignocaine with 1:200,000 adrenaline, and 3 mL of saline. Using the HNS Stimuplex (B. Braun Melsungen AG, Melsungen, Germany) nerve stimulator, 20 mL was given for an ISB and 5 mL for the SCPB. RA was considered successful if there was no conversion to GA and surgery could be performed.
UNASSIGNED: With an onset time of 6.53 ± 2.17 min, good operating conditions were obtained in all our patients. Horner\'s syndrome was noted in two patients. Surgery was successfully carried out in all thirty patients under RA. Pain relief lasted postoperatively for 5 ± 0.92 h.
UNASSIGNED: ISB combined with SCPB is safe and effective as a sole anesthetic for clavicular surgery. We successfully avoided the use of a general anesthetic in these patients during the COVID-19 pandemic and gave them a safe and effective alternative.
摘要：
未经证实：锁骨骨折通常在全身麻醉（GA）下进行，因为它们需要密集的麻醉，术中难以进入气道。锁骨骨折没有确定的区域麻醉（RA）技术，也因为神经支配是有争议的。已经使用RA技术进行了一些研究，但它们都是小案例。RA在很多方面都优于GA，我们特别希望在COVID-19大流行期间避免GA。
UNASSIGNED：这项研究旨在使用周围神经刺激器和基于地标的技术，将肌间沟阻滞（ISB）和颈浅丛阻滞（SCPB）作为唯一的麻醉剂用于COVID-19大流行期间的锁骨骨折手术。
UNASSIGNED：这是一项在印度东部三级护理教学医院进行的前瞻性观察性研究。
UASSIGNED：在我们的伦理委员会批准和知情同意后，30名美国麻醉医师协会I级或II级患者，18-65岁,排除标准后选择必须接受锁骨手术的患者.制作了三个10毫升的注射器，每个用5毫升0.75%的罗哌卡因，2毫升2％利多卡因与1：200,000肾上腺素，和3mL盐水。使用HNS刺激(B.BraunMelsungen公司,Melsungen,德国)神经刺激器，对于ISB给予20mL,对于SCPB给予5mL。如果没有转化为GA并且可以进行手术，则认为RA是成功的。
未经批准：起效时间为6.53±2.17分钟，我们所有患者都获得了良好的手术条件。在两名患者中发现了霍纳综合征。所有30例RA患者均成功进行了手术。术后疼痛缓解持续5±0.92h。
UNASSIGNED：ISB联合SCPB作为锁骨手术的唯一麻醉药是安全有效的。在COVID-19大流行期间，我们成功地避免了这些患者使用全身麻醉药，并为他们提供了安全有效的替代方案。
UNASSIGNED：这项研究旨在使用周围神经刺激器和基于地标的技术，将肌间沟阻滞（ISB）和颈浅丛阻滞（SCPB）作为唯一的麻醉剂用于COVID-19大流行期间的锁骨骨折手术。
UNASSIGNED：这是一项在印度东部三级护理教学医院进行的前瞻性观察性研究。
UASSIGNED：在我们的伦理委员会批准和知情同意后，30名美国麻醉医师协会I级或II级患者，18-65岁,排除标准后选择必须接受锁骨手术的患者.制作了三个10毫升的注射器，每个用5毫升0.75%的罗哌卡因，2毫升2％利多卡因与1：200,000肾上腺素，和3mL盐水。使用HNS刺激(B.BraunMelsungen公司,Melsungen,德国)神经刺激器，对于ISB给予20mL,对于SCPB给予5mL。如果没有转化为GA并且可以进行手术，则认为RA是成功的。
未经批准：起效时间为6.53±2.17分钟，我们所有患者都获得了良好的手术条件。在两名患者中发现了霍纳综合征。所有30例RA患者均成功进行了手术。术后疼痛缓解持续5±0.92h。
UNASSIGNED：ISB联合SCPB作为锁骨手术的唯一麻醉药是安全有效的。在COVID-19大流行期间，我们成功地避免了这些患者使用全身麻醉药，并为他们提供了安全有效的替代方案。
